Cite
Ghahiri A, Mogharehabed N, Movahedi M, et al. Evaluation of intravenous hydroxylethyl starch, intravenous albumin 20%, and oral cabergoline for prevention of ovarian hyperstimulation syndrome in patients undergoing ovulation induction. J Res Med Sci. 2015;20(7):692-6doi: 10.4103/1735-1995.166228.
Ghahiri, A., Mogharehabed, N., Movahedi, M., & Hosseini, N. (2015). Evaluation of intravenous hydroxylethyl starch, intravenous albumin 20%, and oral cabergoline for prevention of ovarian hyperstimulation syndrome in patients undergoing ovulation induction. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 20(7), 692-6. https://doi.org/10.4103/1735-1995.166228
Ghahiri, Ataollah, et al. "Evaluation of intravenous hydroxylethyl starch, intravenous albumin 20%, and oral cabergoline for prevention of ovarian hyperstimulation syndrome in patients undergoing ovulation induction." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 20,7 (2015): 692-6. doi: https://doi.org/10.4103/1735-1995.166228
Ghahiri A, Mogharehabed N, Movahedi M, Hosseini N. Evaluation of intravenous hydroxylethyl starch, intravenous albumin 20%, and oral cabergoline for prevention of ovarian hyperstimulation syndrome in patients undergoing ovulation induction. J Res Med Sci. 2015 Jul;20(7):692-6. doi: 10.4103/1735-1995.166228. PMID: 26622260; PMCID: PMC4638073.
Copy
Download .nbib